U.S. Markets closed
  • S&P 500

    3,638.35
    +8.70 (+0.24%)
     
  • Dow 30

    29,910.37
    +37.90 (+0.13%)
     
  • Nasdaq

    12,205.85
    +111.44 (+0.92%)
     
  • Russell 2000

    1,855.27
    +10.25 (+0.56%)
     
  • Crude Oil

    45.53
    -0.18 (-0.39%)
     
  • Gold

    1,788.10
    -23.10 (-1.28%)
     
  • Silver

    22.55
    -0.81 (-3.46%)
     
  • EUR/USD

    1.1970
    +0.0057 (+0.4788%)
     
  • 10-Yr Bond

    0.8420
    -0.0360 (-4.10%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3314
    -0.0042 (-0.3169%)
     
  • USD/JPY

    104.0850
    -0.1650 (-0.1583%)
     
  • BTC-USD

    17,104.71
    +6.07 (+0.04%)
     
  • CMC Crypto 200

    333.27
    -4.23 (-1.25%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

AMCP Foundation Interns Evaluate COVID-19 Impact, Opioid Overdoses and Biosimilars in Partnership with Pfizer, Inc.

·3 min read

AMCP Foundation Interns Evaluate COVID-19 Impact, Opioid Overdoses and Biosimilars in Partnership with Pfizer, Inc.

AMCP Foundation Interns Evaluate COVID-19 Impact, Opioid Overdoses and Biosimilars in Partnership with Pfizer, Inc.

PR Newswire

ALEXANDRIA, Va., Nov. 20, 2020

ALEXANDRIA, Va., Nov. 20, 2020 /PRNewswire/ -- AMCP Foundation congratulates three student pharmacists who recently completed two innovative programs on managed care pharmacy and nonprofit leadership, through the generous support of Pfizer, Inc.

www.amcp.org/amcp-foundation
www.amcp.org/amcp-foundation

These highly competitive internships develop leadership skills in managed health care and nonprofit settings through real-world experience, relevant research projects, and networking opportunities. Working closely with Pfizer's Medical Outcomes Specialist Team within North America Medical Affairs as well as AMCP Foundation volunteers, interns virtually participated in a certificate training, presentations, and discussions with industry experts.

Following their 10-week placements at health plans and at AMCP Foundation, participants presented posters about their capstones at AMCP Nexus 2020 Virtual on Wednesday, Oct. 21 (view all Nexus 2020 Virtual posters). Research insights include a trend of decreased prescription claim trends for anti-infective, steroid, and cough and cold medication during the COVID-19 shutdown in western New York state. If these decreases were caused in part by decreased social interaction due to stay-at-home orders, there may be a benefit to socially distancing (working from home, remote learning) during illness.

"These once-in-a-lifetime experiences allow trainees to contribute evidence about health care services, while increasing their understanding of the many facets of potential pharmacy careers," said Paula J. Eichenbrenner, MBA, CAE, Executive Director of the AMCP Foundation. "We're extremely proud to once again partner with Pfizer to prepare the next generation of pharmacists who will soon lead managed care organizations, hospitals, and nonprofits."

2020 AMCP Foundation/Pfizer Summer Intern participants are:

AMCP Foundation/Pfizer, Inc. Managed Care Summer Internship

Marin Weiskopf, University of North Carolina, Eshelman School of Pharmacy, Chapel Hill, N.C.

Poster #Z10: Naloxone Prescribing Trends in New Jersey with the Initial Introduction of a Naloxone Administrative Order
Site: Horizon Blue Cross Blue Shield of New Jersey
Preceptor: Hannah Jang, PharmD, RPh
Pfizer Medical Outcomes Specialist: Dean Gianarkis, MS, PharmD
Virtual Preceptor: Christopher J. Bigness, PharmD, BCPS

Palna Mehta, Rutgers University, Ernest Mario School of Pharmacy, Piscataway, N.J.

Poster #U53: A Retrospective Analysis of Outpatient Prescription Claim Trends during the COVID-19 Pandemic
Site: Independent Health
Preceptors: Ying-Fen Swagler PharmD and Mark Wrobel, PharmD
Pfizer Medical Outcomes Specialist: Brian M. Gucwa, PharmD
Virtual Preceptor: Meredith A. Diamond, PharmD

AMCP Foundation/Pfizer, Inc. Managed Care Research & Nonprofit Leadership Summer Internship
Irene Chung, University of Southern California, School of Pharmacy, Los Angeles, Calif.
Poster #U43: Overcoming Biosimilar Barriers: Stakeholder Perspectives on Strategies to Overcome Challenges—A Cross-Sectional Study
Site: AMCP Foundation
Preceptor: Paula J. Eichenbrenner, MBA, CAE
Pfizer Medical Outcomes Specialist: John Spain, PharmD
Virtual Preceptors: Annesha White, PharmD, MS, PhD and Kenneth Garcia, PharmD

About AMCP Foundation
Established in 1990, the 501(c)3 nonprofit AMCP Foundation is the philanthropic arm of the Academy of Managed Care Pharmacy (AMCP). It exists to advance the collective knowledge and insights on major issues associated with the practice of pharmacy in managed care health care settings. By facilitating innovative research initiatives and providing educational opportunities to learn about managed care pharmacy, the AMCP Foundation invests in the future of managed care. Visit www.amcpfoundation.org.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/amcp-foundation-interns-evaluate-covid-19-impact-opioid-overdoses-and-biosimilars-in-partnership-with-pfizer-inc-301178359.html

SOURCE AMCP Foundation